Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy

Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacotherapy 2023-04, Vol.43 (4), p.351-353
Hauptverfasser: Mo, Xiaolan, Chen, Xiujuan, Zeng, Huasong, Zheng, Wei, Ieong, Chifong, Li, Huixian, Huang, Qiongbo, Xu, Zichuan, Yang, Jinlian, Liang, Qianying, Liang, Huiying, Gao, Xia, Huang, Min, Li, Jiali
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Children
Humans
Immunosuppressive Agents - therapeutic use
Kidney diseases
Machine Learning
Nephrotic syndrome
Nephrotic Syndrome - drug therapy
Tacrolimus
Tacrolimus - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 353
container_issue 4
container_start_page 351
container_title Pharmacotherapy
container_volume 43
creator Mo, Xiaolan
Chen, Xiujuan
Zeng, Huasong
Zheng, Wei
Ieong, Chifong
Li, Huixian
Huang, Qiongbo
Xu, Zichuan
Yang, Jinlian
Liang, Qianying
Liang, Huiying
Gao, Xia
Huang, Min
Li, Jiali
description
doi_str_mv 10.1002/phar.2788
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2791707996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2802857296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3138-62521dbdf7beaf75712e68bb94d8631d118c8efb9f0265cdfb8b9fabb80a76663</originalsourceid><addsrcrecordid>eNp1kc1u1TAQRi1ERW8LC14AWWLTLtLazo3tdFddtRSpFagq68g_Y-KS2MFOQHkM3pikt7BAYuWRvqOj8XwIvaXkjBLCzodWpTMmpHyBNlSKqqgp3b5EG8KEKAgh8hAd5fy4oJRv2St0WPKaC0rEBv26h6Gb8RjxLvY9hBHHcIEflEmx8_2UsQ94bAGPCdS4zx02re9sG6PFAYY2xdEbnOdgU-zhAt-pJQ-AO1Ap-PAVWxjBjBmH-AM6rH3sVfoGKWMVLB4SWL-m4Jw3ysyv0YFTXYY3z-8x-nJ99bC7KW4_ffi4u7wtTElLWXBWMWq1dUKDcqISlAGXWtdbK3lJLaXSSHC6doTxylin5TIrrSVRgnNeHqOTvXdI8fsEeWx6nw10nQoQp9wwUVNBRF2v6Pt_0Mc4pbBs1zBJmKwEe6JO99Ryu5wTuGZIfvnq3FDSrD01a0_N2tPCvns2TroH-5f8U8wCnO-Bn76D-f-m5vPN5f2T8jfMV5_1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2802857296</pqid></control><display><type>article</type><title>Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Mo, Xiaolan ; Chen, Xiujuan ; Zeng, Huasong ; Zheng, Wei ; Ieong, Chifong ; Li, Huixian ; Huang, Qiongbo ; Xu, Zichuan ; Yang, Jinlian ; Liang, Qianying ; Liang, Huiying ; Gao, Xia ; Huang, Min ; Li, Jiali</creator><creatorcontrib>Mo, Xiaolan ; Chen, Xiujuan ; Zeng, Huasong ; Zheng, Wei ; Ieong, Chifong ; Li, Huixian ; Huang, Qiongbo ; Xu, Zichuan ; Yang, Jinlian ; Liang, Qianying ; Liang, Huiying ; Gao, Xia ; Huang, Min ; Li, Jiali</creatorcontrib><identifier>ISSN: 0277-0008</identifier><identifier>EISSN: 1875-9114</identifier><identifier>DOI: 10.1002/phar.2788</identifier><identifier>PMID: 36967107</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Biomarkers ; Children ; Humans ; Immunosuppressive Agents - therapeutic use ; Kidney diseases ; Machine Learning ; Nephrotic syndrome ; Nephrotic Syndrome - drug therapy ; Tacrolimus ; Tacrolimus - therapeutic use</subject><ispartof>Pharmacotherapy, 2023-04, Vol.43 (4), p.351-353</ispartof><rights>2023 Pharmacotherapy Publications, Inc.</rights><rights>Copyright © 2023 Pharmacotherapy Publications, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3138-62521dbdf7beaf75712e68bb94d8631d118c8efb9f0265cdfb8b9fabb80a76663</cites><orcidid>0000-0003-3623-3474</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fphar.2788$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fphar.2788$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36967107$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mo, Xiaolan</creatorcontrib><creatorcontrib>Chen, Xiujuan</creatorcontrib><creatorcontrib>Zeng, Huasong</creatorcontrib><creatorcontrib>Zheng, Wei</creatorcontrib><creatorcontrib>Ieong, Chifong</creatorcontrib><creatorcontrib>Li, Huixian</creatorcontrib><creatorcontrib>Huang, Qiongbo</creatorcontrib><creatorcontrib>Xu, Zichuan</creatorcontrib><creatorcontrib>Yang, Jinlian</creatorcontrib><creatorcontrib>Liang, Qianying</creatorcontrib><creatorcontrib>Liang, Huiying</creatorcontrib><creatorcontrib>Gao, Xia</creatorcontrib><creatorcontrib>Huang, Min</creatorcontrib><creatorcontrib>Li, Jiali</creatorcontrib><title>Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy</title><title>Pharmacotherapy</title><addtitle>Pharmacotherapy</addtitle><subject>Biomarkers</subject><subject>Children</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney diseases</subject><subject>Machine Learning</subject><subject>Nephrotic syndrome</subject><subject>Nephrotic Syndrome - drug therapy</subject><subject>Tacrolimus</subject><subject>Tacrolimus - therapeutic use</subject><issn>0277-0008</issn><issn>1875-9114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1TAQRi1ERW8LC14AWWLTLtLazo3tdFddtRSpFagq68g_Y-KS2MFOQHkM3pikt7BAYuWRvqOj8XwIvaXkjBLCzodWpTMmpHyBNlSKqqgp3b5EG8KEKAgh8hAd5fy4oJRv2St0WPKaC0rEBv26h6Gb8RjxLvY9hBHHcIEflEmx8_2UsQ94bAGPCdS4zx02re9sG6PFAYY2xdEbnOdgU-zhAt-pJQ-AO1Ap-PAVWxjBjBmH-AM6rH3sVfoGKWMVLB4SWL-m4Jw3ysyv0YFTXYY3z-8x-nJ99bC7KW4_ffi4u7wtTElLWXBWMWq1dUKDcqISlAGXWtdbK3lJLaXSSHC6doTxylin5TIrrSVRgnNeHqOTvXdI8fsEeWx6nw10nQoQp9wwUVNBRF2v6Pt_0Mc4pbBs1zBJmKwEe6JO99Ryu5wTuGZIfvnq3FDSrD01a0_N2tPCvns2TroH-5f8U8wCnO-Bn76D-f-m5vPN5f2T8jfMV5_1</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Mo, Xiaolan</creator><creator>Chen, Xiujuan</creator><creator>Zeng, Huasong</creator><creator>Zheng, Wei</creator><creator>Ieong, Chifong</creator><creator>Li, Huixian</creator><creator>Huang, Qiongbo</creator><creator>Xu, Zichuan</creator><creator>Yang, Jinlian</creator><creator>Liang, Qianying</creator><creator>Liang, Huiying</creator><creator>Gao, Xia</creator><creator>Huang, Min</creator><creator>Li, Jiali</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3623-3474</orcidid></search><sort><creationdate>202304</creationdate><title>Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy</title><author>Mo, Xiaolan ; Chen, Xiujuan ; Zeng, Huasong ; Zheng, Wei ; Ieong, Chifong ; Li, Huixian ; Huang, Qiongbo ; Xu, Zichuan ; Yang, Jinlian ; Liang, Qianying ; Liang, Huiying ; Gao, Xia ; Huang, Min ; Li, Jiali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3138-62521dbdf7beaf75712e68bb94d8631d118c8efb9f0265cdfb8b9fabb80a76663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomarkers</topic><topic>Children</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney diseases</topic><topic>Machine Learning</topic><topic>Nephrotic syndrome</topic><topic>Nephrotic Syndrome - drug therapy</topic><topic>Tacrolimus</topic><topic>Tacrolimus - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mo, Xiaolan</creatorcontrib><creatorcontrib>Chen, Xiujuan</creatorcontrib><creatorcontrib>Zeng, Huasong</creatorcontrib><creatorcontrib>Zheng, Wei</creatorcontrib><creatorcontrib>Ieong, Chifong</creatorcontrib><creatorcontrib>Li, Huixian</creatorcontrib><creatorcontrib>Huang, Qiongbo</creatorcontrib><creatorcontrib>Xu, Zichuan</creatorcontrib><creatorcontrib>Yang, Jinlian</creatorcontrib><creatorcontrib>Liang, Qianying</creatorcontrib><creatorcontrib>Liang, Huiying</creatorcontrib><creatorcontrib>Gao, Xia</creatorcontrib><creatorcontrib>Huang, Min</creatorcontrib><creatorcontrib>Li, Jiali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mo, Xiaolan</au><au>Chen, Xiujuan</au><au>Zeng, Huasong</au><au>Zheng, Wei</au><au>Ieong, Chifong</au><au>Li, Huixian</au><au>Huang, Qiongbo</au><au>Xu, Zichuan</au><au>Yang, Jinlian</au><au>Liang, Qianying</au><au>Liang, Huiying</au><au>Gao, Xia</au><au>Huang, Min</au><au>Li, Jiali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy</atitle><jtitle>Pharmacotherapy</jtitle><addtitle>Pharmacotherapy</addtitle><date>2023-04</date><risdate>2023</risdate><volume>43</volume><issue>4</issue><spage>351</spage><epage>353</epage><pages>351-353</pages><issn>0277-0008</issn><eissn>1875-9114</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36967107</pmid><doi>10.1002/phar.2788</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-3623-3474</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0277-0008
ispartof Pharmacotherapy, 2023-04, Vol.43 (4), p.351-353
issn 0277-0008
1875-9114
language eng
recordid cdi_proquest_miscellaneous_2791707996
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Biomarkers
Children
Humans
Immunosuppressive Agents - therapeutic use
Kidney diseases
Machine Learning
Nephrotic syndrome
Nephrotic Syndrome - drug therapy
Tacrolimus
Tacrolimus - therapeutic use
title Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T16%3A58%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Comment%20on:%20Tacrolimus%20in%20the%20treatment%20of%20childhood%20nephrotic%20syndrome:%20Machine%20learning%20detects%20novel%20biomarkers%20and%20predicts%20efficacy&rft.jtitle=Pharmacotherapy&rft.au=Mo,%20Xiaolan&rft.date=2023-04&rft.volume=43&rft.issue=4&rft.spage=351&rft.epage=353&rft.pages=351-353&rft.issn=0277-0008&rft.eissn=1875-9114&rft_id=info:doi/10.1002/phar.2788&rft_dat=%3Cproquest_cross%3E2802857296%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2802857296&rft_id=info:pmid/36967107&rfr_iscdi=true